Enavate Sciences GP, LLC

13F Filings History

Latest 13F report
Q3 2025 - Nov 14, 2025
Value $
$328M
Signature - Title
James P. Boylan - Chief Executive Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Enavate Sciences GP, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Enavate Sciences GP, LLC reported 7 stock holdings with total value $328M as of Q3 2025. Top holdings included ZBIO, SION, IMNM, UPB, and BBOT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2025 7 $328M +$30.4M $0 +$30.4M ZBIO, SION, IMNM, UPB, BBOT 13F-HR 11/14/2025, 04:16 PM
Q2 2025 6 $177M $0 $0 IMNM, SION, ZBIO, UPB, CMPX 13F-HR 8/14/2025, 04:18 PM
Q1 2025 6 $133M +$34.6M $0 +$34.6M IMNM, ZBIO, SION, CAMP, UPB 13F-HR 5/15/2025, 04:17 PM
Q4 2024 5 $139M $0 $0 UPB, IMNM, ZBIO, CAMP, CMPX 13F-HR 2/14/2025, 04:15 PM